<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">Eighteen influenza registration records were reviewed (Additional file 
 <xref rid="MOESM1" ref-type="media">1</xref>: appendix 8). There were 16 interventional trials and two observational studies that were enrolling patients during the A(H1N1)pdm09 pandemic period. The treatments under investigation were oseltamivir, sambucol supplement, zanamivir, peramivir, amantadine, pomegranate supplement, nitazoxanide and favipiravir.
</p>
